Acquisition Upsell Fibroblast was acquired by Cerner Corporation in October 2020, signaling potential alignment opportunities for Cerner’s health IT ecosystem and existing clients seeking referral automation as a value add.

Referral Automation The core offering focuses on end-to-end referral tooling to prevent patient leakage and improve revenue cycles, presenting an upsell path to healthcare organizations relying on referral workflows and ACO risk management.

Tech Stack Fit With integrations across Salesforce, Google Cloud, HubSpot, Zendesk Chat, WordPress, and CRM/analytics tools, there is a clear pathway to expand Cerner’s partner and client ecosystems leveraging familiar tech.

Financial Footnote Current revenue is under $1M with a modest funding base; target mid-market or smaller health systems within Cerner’s network to accelerate growth and demonstrate ROI rapidly.

Growth Signals Small-employee profile suggests agility and potential for quick deployments; align sales messaging to Cerner-connected providers and fee-for-service and accountable care organizations seeking ROI in referral management.